apoC-IV Antibodies

Santa Cruz Biotechnology provides a broad selection of apoC-IV monoclonal antibodies for advanced research in lipid metabolism and cardiovascular health. apoC-IV Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Apolipoprotein C-IV (apoC-IV) plays a crucial role in lipid transport and metabolism, influencing triglyceride levels and contributing to the regulation of lipoprotein assembly and clearance. Understanding the function of apoC-IV is essential for elucidating its impact on metabolic disorders and cardiovascular diseases. Research focusing on apoC-IV has revealed significant insights into dyslipidemia and its associated health risks. Scientists can explore the molecular mechanisms of apoC-IV using various detection methods, including fluorescent conjugates such as phycoerythrin (PE), fluorescein isothiocyanate (FITC), and horseradish peroxidase (HRP). Investigating apoC-IV expression patterns helps researchers better understand its role in maintaining lipid homeostasis. Current studies of apoC-IV continue to uncover new aspects of lipid metabolism regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific knowledge in cardiovascular and metabolic research.